RT Journal Article
SR Electronic
T1 Effectiveness of intervention strategies for Coronavirus Disease 2019 and an estimation of its peak time
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.02.19.20025387
DO 10.1101/2020.02.19.20025387
A1 Pan, Jinhua
A1 Yao, Ye
A1 Liu, Zhixi
A1 Li, Mengying
A1 Wang, Ying
A1 Dong, Weizhen
A1 Kan, Haidong
A1 Wang, Weibing
YR 2020
UL http://medrxiv.org/content/early/2020/02/23/2020.02.19.20025387.abstract
AB The Coronavirus Disease 2019 (COVID-19) has been spreading rapidly to other provinces and neighboring countries. Two mathematical SEIR models have been developed to simulate the current epidemic situation in China. The basic reproductive number R0 declined from 5.75 to 1.69 in Wuhan and 6.22 to 1.67 in entire China from 19 January to 16 February 2020. Wuhan is estimated to have reached a peak in the number of confirmed cases on 6 February 2020. The results also show that the peak of new asymptomatic cases per day, new symptomatic infections and COVID-19 inpatients in Wuhan occurred on February 6, February 3 and February 14. The number of confirmed cases would decrease to less than 10 on March 27 in Wuhan and March 19 in the other parts of China. Five cities with top risk index in China (except for Wuhan) are: Huanggang, Xiaogan, Jingzhou, Chongqing, and Xiangyang city. We should take more strict isolation measures to end the epidemic ahead of time.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialThis paper is not a clinical trialsFunding StatementThis study is sponsored by the Bill & Melinda Gates Foundation (OPP1216424) and Shanghai Sailing Program (Grant No. 17YF142600).Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data in this article are all public data obtained from the National Health Commission of the People’s Republic of China.